Cargando…

Influence of Interferon-Alpha Combined with Chemo (Radio) Therapy on Immunological Parameters in Pancreatic Adenocarcinoma

Prognosis of patients with carcinoma of the exocrine pancreas is particularly poor. A combination of chemotherapy with immunotherapy could be an option for treatment of pancreatic cancer. The aim of this study was to perform an immunomonitoring of 17 patients with pancreatic cancer from the CapRI-2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karakhanova, Svetlana, Mosl, Beate, Harig, Sabine, von Ahn, Katharina, Fritz, Jasmin, Schmidt, Jan, Jäger, Dirk, Werner, Jens, Bazhin, Alexandr V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975387/ https://www.ncbi.nlm.nih.gov/pubmed/24608924 http://dx.doi.org/10.3390/ijms15034104

Ejemplares similares

Prognostic and predictive value of immunological parameters for chemoradioimmunotherapy in patients with pancreatic adenocarcinoma
por: Karakhanova, S, et al.
Publicado: (2015)

Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Pivotal antitumor role of the immune checkpoint molecule B7-H1 in pancreatic cancer
por: Bazhin, Alexandr V., et al.
Publicado: (2022)

Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy
por: Bazhin, Alexandr V., et al.
Publicado: (2018)

Overcoming immunosuppression as a new immunotherapeutic approach against pancreatic cancer
por: Bazhin, Alexandr V, et al.
Publicado: (2013)

Reactive Oxygen Species in Cancer Biology and Anticancer Therapy
por: Bazhin, Alexandr V., et al.
Publicado: (2016)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

Subjective voice quality, communicative ability and swallowing after definitive radio(chemo)therapy, laryngectomy plus radio(chemo)therapy, or organ conservation surgery plus radio(chemo)therapy for laryngeal and hypopharyngeal cancer
por: Szuecs, Marcella, et al.
Publicado: (2015)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

Longitudinal atherosclerotic changes after radio(chemo)therapy of hypopharyngeal carcinoma
por: Simonetto, Cristoforo, et al.
Publicado: (2020)

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer
por: Glatzer, Markus, et al.
Publicado: (2016)

Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?
por: Montero, Angel, et al.
Publicado: (2022)

Major combined electrolyte deficiency during therapy with low-dose Cisplatin, 5-Fluorouracil and Interferon alpha: report on several cases and review of the literature [ISRCTN62866759]
por: Hoffmann, Katrin, et al.
Publicado: (2006)

A Randomized Multicentre Phase II Trial Comparing Adjuvant Therapy in Patients with Interferon Alpha-2b and 5-FU Alone or in Combination with Either External Radiation Treatment and Cisplatin (CapRI) or Radiation alone regarding Event-Free Survival – CapRI-2
por: Märten, Angela, et al.
Publicado: (2009)

Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling
por: Wu, Xiaoqing, et al.
Publicado: (2016)

Overestimation of grey matter atrophy in glioblastoma patients following radio(chemo)therapy
por: Gommlich, A., et al.
Publicado: (2021)

Commentary: Immuno-chemo-radio-therapy before esophagectomy: Our next standard?
por: Ripley, R. Taylor
Publicado: (2022)

Pathologic Assessment of Rectal Carcinoma after Neoadjuvant Radio(chemo)therapy: Prognostic Implications
por: Hav, Monirath, et al.
Publicado: (2015)

Stent patency in patients with distal malignant biliary obstruction receiving chemo(radio)therapy
por: Haal, Sylke, et al.
Publicado: (2017)

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
por: Hingorani, Dina V., et al.
Publicado: (2022)

Editorial: Combining chemo/radio therapy and immunotherapy for cancers—perfect mix of old and new
por: Slaney, Clare Y., et al.
Publicado: (2023)

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : II. IMMUNOLOGICAL SPECIFICITY OF SYNTHETIC SUGAR-PROTEIN ANTIGENS
por: Avery, Oswald T., et al.
Publicado: (1929)

Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer
por: Li, Ling, et al.
Publicado: (2016)

Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer
por: Ye, Shu-Biao, et al.
Publicado: (2020)

Catechol enhances chemo- and radio-sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells
por: Moon, Jeong Yong, et al.
Publicado: (2021)

Mitochondria and Cancer
por: Bazhin, Alexandr V.
Publicado: (2020)

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : XII. THE IMMUNOLOGICAL PROPERTIES OF AN ARTIFICIAL ANTIGEN CONTAINING CELLOBIURONIC ACID
por: Goebel, Walther F.
Publicado: (1938)

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : XII. THE IMMUNOLOGICAL PROPERTIES OF AN ARTIFICIAL ANTIGEN CONTAINING CELLOBIURONIC ACID
por: Goebel, Walther F.
Publicado: (1938)

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : X. THE IMMUNOLOGICAL PROPERTIES OF AN ARTIFICIAL ANTIGEN CONTAINING GLUCURONIC ACID
por: Goebel, Walther F.
Publicado: (1936)

CD96 as a Potential Immune Regulator in Cancers
por: Feng, Shikai, et al.
Publicado: (2023)

Immunological effects of alternative weekly interferon-alpha-2b and low dose interleukin-2 in patients with cancer.
por: Fiorentino, B., et al.
Publicado: (1992)

Predictive Immunological Markers in Oncology
por: Jäger, Dirk, et al.
Publicado: (2012)

Interferon α interferes with immunological tolerance
por: Becker, Christian, et al.
Publicado: (2013)

Canine Mammary Cancer Stem Cells are Radio- and Chemo-Resistant and Exhibit an Epithelial-Mesenchymal Transition Phenotype
por: Pang, Lisa Y., et al.
Publicado: (2011)

Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients?
por: Münch, Stefan, et al.
Publicado: (2017)

PO-0951 Effects of COVID-19 during radio(chemo)therapy in head and neck cancer patients
por: Bandurska-Luque, A., et al.
Publicado: (2021)

A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers
por: Ademaj, Adela, et al.
Publicado: (2022)

Exploring Three Avenues: Chemo- and Regioselective Transformations of 1,2,4-Triketone Analogs into Pyrazoles and Pyridazinones
por: Edilova, Yulia O., et al.
Publicado: (2023)

Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)
por: Hassel, Jessica C., et al.
Publicado: (2022)

To Chemo or Not to Chemo… That Is the Question
por: Martin, Maria Felisa Eva B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eo6r94rdg6s4n2tbqqh1gjrs9g